UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Net Income Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual net income in 2023 was -84.1 Million TWD , up 7.73% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly net income in 2024 Q2 was -25.95 Million TWD , up 17.63% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported an annual net income of -91.15 Million TWD in 2022, down -5.54% from previous year.
  • UnicoCell Biomed Co., Ltd. reported an annual net income of -86.37 Million TWD in 2021, up 20.91% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a quarterly net income of -31.51 Million TWD for 2024 Q1, down -23.38% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a quarterly net income of -25.54 Million TWD for 2023 Q3, down -64.1% from previous quarter.

Annual Net Income Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Net Income of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Net Income Net Income Growth
2023 -84.1 Million TWD 7.73%
2022 -91.15 Million TWD -5.54%
2021 -86.37 Million TWD 20.91%
2020 -109.2 Million TWD -8.19%
2019 -100.93 Million TWD 0.0%

Peer Net Income Comparison of UnicoCell Biomed Co., Ltd.

Name Net Income Net Income Difference
Apex Biotechnology Corp. 115.78 Million TWD 172.643%
Sinphar Pharmaceutical Co.,Ltd. 375.17 Million TWD 122.419%
Panion & Bf Biotech Inc. 77.21 Million TWD 208.921%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 264.9 Million TWD 131.75%
GenMont Biotech Incorporation 32.99 Million TWD 354.942%
Abnova (Taiwan) Corporation 43.67 Million TWD 292.564%
Adimmune Corporation -639.89 Million TWD 86.856%
Tanvex BioPharma, Inc. -2.13 Billion TWD 96.064%
Polaris Group -1.57 Billion TWD 94.666%
Energenesis Biomedical CO.,LTD. -260.38 Million TWD 67.698%
PELL Bio-Med Technology Co. Ltd. -398.75 Million TWD 78.907%